Drug intelligence / Profile preview

isoetharine

Development stage
Discontinued
Modality
Small Molecules
Administration
Inhalation
01

Overview

Isoetharine is a selective, short-acting beta-2 adrenergic receptor agonist and bronchodilator. It acts by stimulating beta-2 adrenergic receptors in bronchial smooth muscle, leading to activation of adenylyl cyclase and increased cyclic AMP (cAMP) levels. This results in relaxation of bronchial smooth muscle, improved airway patency, and relief from symptoms such as wheezing, shortness of breath, coughing, and chest tightness associated with asthma, chronic bronchitis, emphysema, and other obstructive lung diseases. Isoetharine was one of the early selective beta agonists developed after epinephrine and isoprenaline for rapid relief of bronchospasm. It is no longer available in the United States but remains available in some countries including Germany, India, and Japan[1][3][5][6].

Brand names
BronkometerBronkosol
Other names
isoetarinaisoetarinumisoetharine mesylate
02

Targets

ADRB1 (β1)ADRB2 (β2)

Beyond the preview

Go deeper on isoetharine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isoetharine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call